Springer Nature
Browse
12916_2021_2120_MOESM1_ESM.docx (37.5 kB)

Additional file 1 of Impact of clinical phenotypes on management and outcomes in European atrial fibrillation patients: a report from the ESC-EHRA EURObservational Research Programme in AF (EORP-AF) General Long-Term Registry

Download (37.5 kB)
journal contribution
posted on 2021-10-20, 03:24 authored by Marco Proietti, Marco Vitolo, Stephanie L. Harrison, Deirdre A. Lane, Laurent Fauchier, Francisco Marin, Michael Nabauer, Tatjana S. Potpara, Gheorghe-Andrei Dan, Giuseppe Boriani, Gregory Y. H. Lip
Additional file 1 : Table S1. Use of Antithrombotic drugs according to Patient Clusters in patients with High Thromboembolic Risk. STROBE Checklist. Appendix. EURObservational Research Programme Atrial Fibrillation (EORP-AF) Long-Term General Registry Committees and Investigators.

Funding

Abbott Vascular Amgen Cardiovascular AstraZeneca Bayer Boehringer Ingelheim Boston Scientific Corporation The Bristol Myers Squibb and Pfizer Alliance The Alliance Daiichi Sankyo Europe GmbH and Eli Lilly and Company Edwards Lifesciences Gedeon Richter Fondazione Internazionale Menarini MSD-Merck & Co. Novartis Pharma (DE) ResMed Sanofi Servier (FR) Vifor Pharma

History

Usage metrics

    BMC Medicine

    Categories

    Keywords

    Atrial fibrillationClinical phenotypesCluster analysisClinical managementMajor adverse outcomes

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC